Leuprolide acetate 7.5mg; depot susp for IM inj; preservative-free. Give as single IM inj into gluteal area, anterior thigh or deltoid; rotate inj sites. 7.5mg once a month (4 weeks). Initial ...

Leuprolide acetate 3.75mg; depot susp for IM inj; preservative-free. Leuprolide acetate is a long-acting GnRH analog. A single monthly injection of results in an initial stimulation followed by a ...

Dr. Josie Tenore and Paul Hinds were introduced by a mutual friend in 2017 and hadn't been going out long when she laid down the law: He had to get a physical. "I don't date people who don't take care ...

ABBOTT PARK, Ill., June 20, 2011 /PRNewswire/ -- Abbott announced today that the U.S. Food and Drug Administration (FDA) has approved a new 45 mg for six-month administration formulation of Lupron ...

Cipla is introducing leuprolide acetate injection depot, 22.5 mg, which is the generic of AbbVie’s Lupron Depot. It is indicated for palliative treatment of advanced prostate cancer. Leuprolide ...

ABBOTT PARK, Ill., Aug. 16, 2011 /PRNewswire/ -- Abbott (NYSE: ABT) announced today that the U.S. Food and Drug Administration (FDA) has approved two new strengths for three-month administration of ...

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/cvwck3/lupron_depot) has announced the addition of GlobalData's new report ...

AbbVie (ABBV) announced that a new 6-month 45mg Lupron Depot strength has received Health Canada approval for the treatment of advanced prostate cancer. Lupron Depot is now available in four dosing ...

Endometriosis is a common gynecological condition in which tissue similar to the tissue normally found lining the inside of the uterus is found on the outside of the uterus. This tissue outside the ...